Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Brainsway (BRSYF) Stock Price & Analysis

BRSYF Stock Chart & Stats

$11.77$0.77(7.00%)
At close: 4:00 PM EDT
$11$11.5$12$12.52 Oct21 Oct30 Oct
Day’s Range
$11.77 - $12.55
52-Week Range
$5.49 - $18.88
Previous Close
$11.00
Volume
20
Average Volume (3M)
33
Market Cap
$477.85M
Enterprise Value
$1.68B
Total Cash (Recent Filing)
$61.94M
Total Debt (Recent Filing)
$7.13M
Price to Earnings (P/E)
49.2
Beta
0.50
Next Earnings
Nov 10, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Strong reported growth and higher full-year guidance indicate accelerating demand and improving commercial execution. If maintained, this expansion can increase operating leverage, support continued investment in the platform, and strengthen BrainsWay’s position in neuromodulation over the coming quarters.

Installed Base Expansion

A larger installed base supports recurring utilization, service, accessories, and lease-related revenue beyond the initial system sale. Continued placements also expand clinical reach and create a broader foundation for future growth as providers gain experience with Deep TMS.

Balance Sheet Strength

Low leverage and expanding equity provide financial flexibility to fund clinical development, commercial expansion, and customer support without substantial refinancing pressure. This conservative capital structure can help BrainsWay sustain investment while protecting resilience if growth or cash conversion becomes uneven.

Bears Say

Cash Flow Volatility

The decline in free cash flow and weaker cash conversion show that improved accounting profitability has not translated consistently into cash generation. Working-capital movements or higher cash costs could constrain internally funded growth and make financial planning less predictable over the next several quarters.

Reimbursement Variability

Uneven reimbursement can slow provider adoption even when clinical evidence is favorable, because clinics need dependable payment economics to deploy and use the systems. This creates a structural commercialization risk across markets and may lengthen the period required to convert demand into recurring revenue.

Operating Expense Pressure

Rapid increases in research, development, and administrative spending can limit operating leverage if revenue growth moderates. Although margins improved, sustained cost growth raises the execution burden and could delay the full conversion of expanding sales into durable operating profit and cash flow.

Brainsway News

BRSYF FAQ

What was Brainsway’s price range in the past 12 months?
Brainsway lowest stock price was $5.49 and its highest was $18.88 in the past 12 months.
What is Brainsway’s market cap?
Brainsway’s market cap is $477.85M.
When is Brainsway’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Brainsway’s earnings last quarter?
Brainsway released its earnings results on Aug 12, 2026. The company reported $0.064 earnings per share for the quarter.
Is Brainsway overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Brainsway pay dividends?
Brainsway does not currently pay dividends.
What is Brainsway’s EPS estimate?
Brainsway’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brainsway have?
Brainsway has 40,252,990 shares outstanding.
What happened to Brainsway’s price movement after its last earnings report?
Brainsway reported an EPS of $0.064 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Brainsway?
Currently, no hedge funds are holding shares in BRSYF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology